Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $913.04 billion, total revenue of $172.71 billion and a weighted average PE ratio of 50.47.
Market Cap
913.04B
Revenue
172.71B
Profits
18.09B
PE Ratio
50.47
Profit Margin
10.47%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 251.28B | 0.15% | 1,850,867 | 46.34B |
| 2 | DHR | Danaher Corporation | 158.95B | -0.54% | 3,608,533 | 25.11B |
| 3 | NTRA | Natera, Inc. | 59.75B | 0.67% | 2,058,203 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 49.35B | -0.10% | 2,053,880 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 44.28B | -0.73% | 1,174,130 | 16.98B |
| 6 | WAT | Waters Corporation | 43.55B | 0.07% | 625,637 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 42.02B | 0.83% | 648,950 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 41.07B | 0.04% | 2,229,743 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 30.80B | -0.51% | 144,788 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.60B | -2.38% | 1,536,906 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 25.04B | -0.25% | 613,108 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 23.85B | 0.23% | 1,658,542 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.36B | 1.00% | 250,692 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 17.05B | 1.16% | 1,601,168 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 14.13B | 0.47% | 661,450 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 13.14B | -2.97% | 1,442,757 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.18B | -1.36% | 4,231,945 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 6.10B | 2.97% | 922,969 | 165.26M |
| 19 | BLLN | BillionToOne, Inc. | 5.58B | -2.91% | 440,450 | 397.41M |
| 20 | RDNT | RadNet, Inc. | 5.56B | -1.62% | 501,037 | 2.27B |
| 21 | SHC | Sotera Health Company | 5.31B | 0.81% | 1,643,394 | 1.22B |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.59B | 0.91% | 2,508,235 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.70B | 1.88% | 1,594,817 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.31B | -0.90% | 796,309 | 458.09M |
| 25 | NEO | NeoGenomics, Inc. | 2.41B | -2.85% | 2,695,715 | 766.30M |
| 26 | WGS | GeneDx Holdings Corp. | 2.26B | -11.80% | 1,334,405 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.75B | 0.18% | 1,037,832 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.71B | -1.67% | 508,222 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.21B | -0.61% | 1,727,889 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.07B | -2.92% | 318,619 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 607.54M | -1.25% | 234,849 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 404.60M | -0.24% | 1,599,335 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 307.46M | -4.21% | 142,731 | 102.94M |
| 34 | XGN | Exagen Inc. | 201.07M | -2.12% | 217,821 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 199.75M | 7.43% | 58,716 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 110.61M | 6.29% | 311,221 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 108.45M | -5.15% | 232,349 | 537.08K |
| 38 | MDXH | MDxHealth SA | 49.62M | -5.11% | 311,049 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 42.21M | -2.20% | 63,080 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 10.44M | -6.09% | 19,574 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 8.82M | 1.38% | 22,124 | - |
| 42 | XWEL | XWELL, Inc. | 7.39M | -4.02% | 30,482 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 3.71M | -7.15% | 150,295 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 3.10M | 1.65% | 126,537 | 466.30K |